Why is P & G Health Ltd falling/rising?

As of 11-Jun, Procter & Gamble Health Ltd is experiencing a price increase, currently trading at 5,851.45, which reflects a rise of 41.45 or 0.71%. The stock has been gaining momentum, having risen 5.56% over the last three days and is currently just 1.51% away from its 52-week high. It is performing well against its moving averages, trading above the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The company has shown strong financial performance with positive results over the last three consecutive quarters, including a significant growth in net sales and profit before tax. However, there are concerns regarding long-term growth, as net sales have only grown at an annual rate of 5.69% over the last five years, and the stock is considered very expensive based on its price-to-book value.
In the broader market context, Procter & Gamble Health Ltd has outperformed the benchmark Sensex, with a 1-week return of 4.28% compared to the Sensex's 1.87%, and a 1-month return of 16.37% against the Sensex's 3.85%. This strong performance relative to the market is likely contributing to investor confidence, despite a slight decline in delivery volume, which may indicate falling investor participation. The high institutional holdings at 21.08% suggest that knowledgeable investors are backing the stock, further supporting its upward movement. Overall, the combination of strong recent performance, positive financial results, and favorable technical indicators are driving the stock's rise, even as some long-term growth concerns linger.